FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Commercial · sales Supplies vaccines and rare-disease treatments in Korea and is widening clinical partnerships with Korean hospitals.

  • Announced an agreement with Seoul National University Hospital on future clinical trial innovation. Source
  • Announced the Korean launch of the RSV-prevention antibody Beyfortus. Source

Roles often seen at this stageSales & marketing · Medical & MSL · Regulatory affairs

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

Sanofi Korea

The Korean arm of global drugmaker Sanofi, supplying vaccines and treatments for immune diseases, rare diseases, diabetes and cancer in Korea.

Beyfortus

Marketed

An RSV-prevention antibody injection for all newborns and infants, prescribed in Korea since 5 February 2025.

Alprolix

Marketed

A haemophilia B treatment; a May 2026 label change in Korea allows storage at up to 30°C for as long as six months.

Completion reported

A Korean label change allowing room-temperature storage of the haemophilia drug Alprolix took effect.

Completion reported

Signed an agreement with Seoul National University Hospital on AI- and digital-based clinical trial innovation.

Completion reported

Signed an MOU with Deepcardio to improve diagnosis of Fabry disease.

Official role guide

Sanofi Korea careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 5

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 사노피 코리아 ↗사노피 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable
  2. 사노피, RSV 예방 항체주사 베이포투스 출시 ↗아시아경제 · Published 2025-02-06 · Sources checked 2026-11-18 · Original unavailable
  3. 사노피 알프로릭스 허가사항 변경…실온 보관 최대 6개월 ↗메디칼타임즈 · Published 2026-05-20 · Sources checked 2026-11-18 · Original unavailable
  4. 사노피, 서울대학교병원과 '미래 임상 혁신'을 위한 업무 협약 체결 ↗사노피 · Published 2025-06-04 · Sources checked 2026-11-18 · Original unavailable
  5. 사노피 소식 ↗사노피 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable